Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Europe stock lower; banks fall after Morgan Stanley

Published 07/22/2009, 09:17 AM
Updated 07/22/2009, 09:24 AM
UK100
-
BARC
-
BP
-
UBSN
-
BNPP
-
TTEF
-
GSK
-
BHPB
-
HBR
-
WFC
-
MS
-

* FTSEurofirst 300 index down 0.4 percent

* Banks fall after Morgan Stanley, Wells Fargo earnings

* GlaxoSmithKline gains after results

By Joanne Frearson

LONDON, July 22 (Reuters) - European shares were down in afternoon trade on Wednesday, with banks leading the decline after quarterly results from U.S. banks Morgan Stanley and Wells Fargo disappointed investors.

By 1306 GMT, the pan-European FTSEurofirst 300 index of top shares was down 0.4 percent at 884.79 points after trading between 879.97 and 888.23 points.

"Morgan Stanley's operating loss per share looks on the high side, compared to others in the sector. I think Morgan Stanley's paying back public aid has distorted results; it is not known if this has been incorporated into analysts' expectations of the results," said Heino Ruland, strategist at Ruland Research.

Bank shares took the most off the index after Morgan Stanley reported its third consecutive quarterly loss and Wells Fargo reported rising credit losses.

"The continuing decline in asset quality is a worry, and whilst they are making money in other areas it just goes to show that conditions in the consumer segment are still evidencing headwinds," said Paul Chesterton, senior sales trader at CMC Markets.

Barclays, BNP Paribas, UBS and Lloyds Banking Group were down 1.5-3.8 percent.

Miners were also heading lower. BHP Billiton fell 2.8 percent after the world's largest miner reported a 10 percent fall in iron ore output to 27.048 million tonnes after its operations were hit by mining fatalities and flooding in Australia.

Energy stocks were down as crude slipped 1.5 percent. BP, Royal Dutch Shell, Premier Oil and Total were 0.8-2.8 percent weaker.

On the upside, drug makers added most points to the index. GlaxoSmithKline gained 0.3 percent after it beat expectations with its second-quarter earnings and said momentum in the second half would pick up on the back of flu vaccine sales.

Across Europe, the FTSE 100 index was down 0.3 percent, Germany's DAX was down 0.4 percent, and France's CAC 40 was down 0.8 percent. (Reporting by Joanne Frearson, editing by Will Waterman)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.